Scientific Advisory Board

Benjamin G. Neel, M.D., Ph.D.

Dr. Benjamin Neel has strong experience in oncology, cancer cell signaling pathways, the role of pathway mutations, and their effects on disease development and cancer genomics. He is a Professor of Medicine at NYU Grossman School of Medicine, where he previously served as Director of its Perlmutter Cancer Center. Prior to joining NYU Langone, he served as Director of the Princess Margaret Cancer Center at University Health Network, which includes the Ontario Cancer Institute and Campbell Family Cancer Research Institute. Dr. Neel was also the William B. Castle Professor of Medicine at Harvard Medical School. He is a Founder of Northern Biologics Inc. and previously served as a member of the Board of Directors. He is also a Founder of Navire Pharma, Inc. and the former Chair of its Scientific Advisory Board, and a Founder of Light Horse Therapeutics and Aethon Therapeutics. Dr. Neel previously served as a Director of the American Association of Cancer Research and currently is on the Board of Directors of the American Association of Cancer Institutes. He was also a member of the Medical Advisory Board of the Gairdner Foundation. He is an elected member of the American Association of Physicians, The Royal Society of Canada and the U.S. National Academy of Sciences.